✦ LIBER ✦
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
✍ Scribed by Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 768 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.